Insider sale trims Slide Insurance board member's stake by 54%

Rhea-AI Filing Summary

Slide Insurance (NYSE:SLDE) filed Form 4 on 06/26/2025 disclosing that director Stephen L. Rohde sold 11,082 common shares on 06/23/2025 at $15.81, generating roughly $175 K in proceeds. The sale was executed under the 06/17/2025 IPO underwriting agreement. Following the transaction, Rohde’s direct ownership fell to 9,335 shares, representing an estimated 54 % reduction of his stake. No derivative security activity or indirect holdings were reported. The filing reflects planned IPO-related liquidity rather than ordinary-course trading but still materially trims insider alignment.

Positive

• None.

Negative

• Director Stephen L. Rohde sold 11,082 shares (~54 % of his stake) for approximately $175 K, cutting direct ownership to 9,335 shares.

Insights

Insider Trading Analyst

Director unloads 54 % of holdings, potential negative sentiment.

The 11,082-share disposition removes more than half of Rohde’s equity at IPO pricing, signalling limited post-listing commitment. Although proceeds are modest (~$175 K), insider confidence optics matter; no offsetting purchases were disclosed. Market may view the quick reduction by a board member as a mild negative overhang.

Corporate Governance Expert

Pre-planned IPO sale; governance risk largely muted.

The filing specifies the sale was governed by the 06/17/25 underwriting agreement, a customary IPO mechanism that lessens information asymmetry. Compliance with Section 16 reporting and absence of derivative hedging support transparency. Remaining 9,335-share stake retains some alignment, so strategic impact is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROHDE STEPHEN L

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.,

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2025		S		11,082(1)	D	$15.81(1)	9,335	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to an underwriting agreement dated as of June 17, 2025, by and among the issuer, the selling stockholders and the underwriters named therein in connection with the issuer's initial public offering.

	/s/ Jesse Schalk, Attorney-in-Fact for Stephen Rohde	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Slide Insurance shares did director Stephen L. Rohde sell on June 23, 2025?

He sold 11,082 shares according to the Form 4.

What was the sale price per SLDE share in Rohde's transaction?

The reported sale price was $15.81 per share.

How many SLDE shares does Rohde own after the reported sale?

Post-sale, he directly owns 9,335 shares.

Was the insider sale connected to Slide Insurance's IPO?

Yes. The shares were sold under the 06/17/2025 IPO underwriting agreement.

What percentage of Rohde's stake was sold in this transaction?

Approximately 54 % of his pre-sale holdings.

Did the Form 4 disclose any derivative security activity?

No derivative securities were reported in the filing.